Regeneron Pharmaceuticals, Inc. SEC filings REGN
Regeneron Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Sep 13, 2017. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Oct 31, 2024 | — |
| S-3ASR | Automatic shelf registration | Nov 4, 2021 | — |
| 424B5 | Prospectus supplement | Aug 11, 2020 | — |
| FWP | Free writing prospectus | Aug 7, 2020 | — |
| 424B3 | Prospectus | Aug 7, 2020 | — |
| S-8 | Employee stock plan registration | Jun 16, 2020 | — |
| 424B3 | Prospectus | May 28, 2020 | — |
| 424B3 | Prospectus | May 26, 2020 | — |
| FWP | Free writing prospectus | May 26, 2020 | — |
| FWP | Free writing prospectus | May 26, 2020 | — |
| S-3ASR | Automatic shelf registration | Nov 13, 2018 | — |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- REGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NY
- Headquarters
- Tarrytown, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 872589
- Former names
- REGENERON PHARMACEUTICALS INC (until Jun 19, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.